NUBEQA 300 mg film-coated tablets

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

1. What NUBEQA is and what it is used for
2. What you need to know before you take NUBEQA
3. How to take NUBEQA
4. Possible side effects
5. How to store NUBEQA
6. Contents of the pack and other information

How NUBEQA works

NUBEQA blocks the activity of male sex hormones called androgens, such as testosterone. By blocking these hormones, darolutamide stops prostate cancer cells from growing and dividing.

Do not take NUBEQA if

• you are allergic to darolutamide or any of the other ingredients of this medicine (listed in section 6)
• you are a woman who is or may become pregnant.

Warnings and precautions

Talk to your doctor or pharmacist before taking NUBEQA if

• you have problems with your kidneys
• you have problems with your liver
• you have any heart conditions including heart rhythm problems or if you are using medicines for these conditions
• you had a surgery to treat blood vessel conditions.

Children and adolescents

This medicine is not for use in children and adolescents under 18 years. Prostate cancer does not occur in this age group.

Other medicines and NUBEQA

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

The following medicines may influence the effect of NUBEQA, or NUBEQA may influence the effect of these medicines to treat:

• bacterial infections, such as rifampicin
• epilepsy, such as carbamazepine, phenobarbital, phenytoin
• symptoms of slightly low mood and mild anxiety: St. John's wort (a herbal medicine)
• high cholesterol, such as rosuvastatin, fluvastatin, atorvastatin, pitavastatin
• severe joint inflammation, severe cases of the skin disease psoriasis, and cancers: methotrexate
• inflammatory bowel diseases: sulfasalazine

Your doctor may therefore change the dose of the medicines that you are taking.

Pregnancy, breast-feeding and fertility

NUBEQA is not for use in women.

This medicine could possibly have an effect on male fertility.

Follow these advices during and for 1 week after stopping:

• use a highly effective method of contraception to prevent pregnancy, if you are having sex with a woman who can become pregnant.
• use a condom to protect the unborn baby, if you are having sex with a pregnant woman.

Driving and using machines

This medicine is unlikely to affect your ability to drive and use machines.

NUBEQA contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

The recommended dose is

2 tablets 2 times daily

Your doctor may reduce your dose to 1 tablet 2 times daily, if you have problems with your liver or kidneys.

Method of use

Swallow the tablets whole, take them with food and a glass of water.

Your doctor may also prescribe other medicines while you are taking NUBEQA.

If you take more NUBEQA than you should

Continue the treatment with the next dose as scheduled.

If you forget to take NUBEQA

Take your missed dose as soon as you remember before the next scheduled dose. Do not take a double dose to make up for 1 or more forgotten tablets.

If you stop taking NUBEQA

Do not stop taking this medicine unless your doctor tells you to.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can help provide more information on the safety of this medicine.

United Kingdom

or search for MHRA Yellow Card in the Google Play or Apple App Store.

What NUBEQA contains

The active substance is darolutamide. Each film-coated tablet contains 300 mg of darolutamide.

The other ingredients are:

• calcium hydrogen phosphate (E 341)
• croscarmellose sodium
• hypromellose
• lactose monohydrate
• macrogol (E 1521)
• magnesium stearate (E 470b)
• povidone (E 1201)
• titanium dioxide (E 171)

See “NUBEQA contains lactose” in section 2 for more information.

What NUBEQA looks like and contents of the pack

The film-coated tablets (tablets) are white to off-white, oval with a length of 16 mm and a width of 8 mm. They are marked with “300” on one side, and “BAYER” on the other side.

Each carton contains:

• 96 film-coated tablets consisting of 6 blisters or
• 112 film-coated tablets consisting of 7 blisters

Each blister contains 16 film-coated tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Manufacturer